Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Neurocrine Biosciences Inc (NBIX) vs Unity Software Inc (U) Price & Performance

Neurocrine Biosciences IncTrade
Unity Software IncTrade

Price performance (Past 24H)

Key statistics

Neurocrine Biosciences Inc vs Unity Software Inc — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Unity Software Inc trades at $29.81 (market cap $13.01B). The key difference: Neurocrine Biosciences Inc is the larger of the two by market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Unity Software Inc nearer its low. Which is the better fit depends on your goals.

NBIXU
Market Cap
$17.40B$13.01B
Sector
HealthTechnology
52-Week High
$180.55$49.47
52-Week Low
$123.10$17.13
Enterprise Value
$16.49B$13.11B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX

About Unity Software Inc

Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.

Read more on U